Bio Medica Laboratories Limited (NSE:BMLL)

India flag India · Delayed Price · Currency is INR
132.75
-2.05 (-1.52%)
At close: Jun 16, 2026
Market Cap1.68B
Revenue (ttm)381.95M +195.5%
Net Income97.95M +2,130.0%
EPS10.67 +2,130.3%
Shares Out 12.58M
PE Ratio12.52
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume19,000
Open133.05
Previous Close134.80
Day's Range130.00 - 136.00
52-Week Range101.50 - 139.90
Betan/a
Analystsn/a
Price Targetn/a
Earnings DateAug 7, 2026

About Bio Medica Laboratories

Bio Medica Laboratories Limited engages in manufacturing pharmaceutical parenteral formulations in India. It manufactures variety of products, comprising ethical drugs, generic drugs and over the-counter drugs in the form of injectables namely Liquid Injections and dry powder injections. It provides human injectables, export of injectables, veterinary injectables, contract manufacturing, quality assurance, and research and development services. The company caters to human and veterinary needs. The company was formerly known as Bio Medica Labora... [Read more]

Industry Pharmaceutical Preparations
Founded 1988
Employees 37
Stock Exchange National Stock Exchange of India
Ticker Symbol BMLL
Full Company Profile

Financial Performance

In fiscal year 2025, Bio Medica Laboratories's revenue was 381.95 million, an increase of 150.47% compared to the previous year's 152.49 million. Earnings were 97.95 million, an increase of 272.23%.

Financial Statements